GPP
Great Point Partners Portfolio holdings
AUM
$154M
This Quarter Return
+71.81%
1 Year Return
-2.36%
3 Year Return
+169.3%
5 Year Return
+292.82%
10 Year Return
+3,519.88%
AUM
$1.04B
AUM Growth
+$1.04B
(+10%)
Cap. Flow
-$156M
Cap. Flow
% of AUM
-14.99%
Top 10 Holdings %
Top 10 Hldgs %
69.3%
Holding
51
New
15
Increased
5
Reduced
11
Closed
15
Top Buys
| 1 |
NextCure
NXTC
|
$63.9M |
| 2 |
TG Therapeutics
TGTX
|
$60.3M |
| 3 |
SAGE
Sage Therapeutics
SAGE
|
$57.5M |
| 4 |
CNST
Constellation Pharmaceuticals, Inc.
CNST
|
$53.5M |
| 5 |
MNTA
Momenta Pharmaceuticals, Inc.
MNTA
|
$35.3M |
Top Sells
| 1 |
ZGNX
Zogenix, Inc.
ZGNX
|
$82.4M |
| 2 |
BOLD
Audentes Therapeutics, Inc
BOLD
|
$69.8M |
| 3 |
Penumbra
PEN
|
$40.3M |
| 4 |
Acadia Pharmaceuticals
ACAD
|
$40.2M |
| 5 |
Nektar Therapeutics
NKTR
|
$38.7M |
Sector Composition
| 1 | Healthcare | 95.48% |
